Profile | GDS5420 / 222556_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 231.82 | 55 |
GSM1296119 | B_lesional_pre-dose | 1007.25 | 79 |
GSM1296076 | C_lesional_pre-dose | 778.17 | 75 |
GSM1296092 | D_lesional_pre-dose | 698.89 | 73 |
GSM1296103 | E_lesional_pre-dose | 459.85 | 66 |
GSM1296078 | F_lesional_pre-dose | 756.22 | 75 |
GSM1296107 | G_lesional_pre-dose | 831.3 | 76 |
GSM1296109 | H_lesional_pre-dose | 552.47 | 69 |
GSM1296080 | I_lesional_pre-dose | 198.74 | 53 |
GSM1296090 | J_lesional_pre-dose | 823.35 | 76 |
GSM1296074 | K_lesional_pre-dose | 697.5 | 74 |
GSM1296111 | L_lesional_pre-dose | 1042.99 | 80 |
GSM1296099 | M_lesional_pre-dose | 831.86 | 76 |
GSM1296086 | O_lesional_pre-dose | 814.57 | 76 |
GSM1296117 | P_lesional_pre-dose | 990.18 | 79 |
GSM1296113 | Q_lesional_pre-dose | 665.07 | 73 |
GSM1296096 | R_lesional_pre-dose | 784.01 | 75 |
GSM1296105 | S_lesional_pre-dose | 364.61 | 62 |
GSM1296098 | T_lesional_pre-dose | 260.57 | 56 |
GSM1296101 | U_lesional_pre-dose | 329.25 | 60 |
GSM1296121 | V_lesional_pre-dose | 1002.92 | 79 |
GSM1296088 | W_lesional_pre-dose | 499.2 | 68 |
GSM1296082 | X_lesional_pre-dose | 969.62 | 79 |
GSM1296115 | Y_lesional_pre-dose | 1122.94 | 81 |
GSM1296084 | Z_lesional_pre-dose | 421.31 | 65 |
GSM1296072 | B_lesional_day8 | 734.82 | 74 |
GSM1296069 | L_lesional_day8 | 1019.83 | 80 |
GSM1296071 | P_lesional_day8 | 741.62 | 74 |
GSM1296070 | Y_lesional_day8 | 872.4 | 77 |
GSM1296073 | V_lesional_day8 | 991.9 | 79 |
GSM1296034 | A_lesional_day15 | 108.18 | 41 |
GSM1296041 | G_lesional_day15 | 961.14 | 79 |
GSM1296035 | R_lesional_day15 | 640.61 | 72 |
GSM1296038 | U_lesional_day15 | 785.32 | 75 |
GSM1296047 | B_lesional_day15 | 710.62 | 74 |
GSM1296039 | E_lesional_day15 | 1018.45 | 80 |
GSM1296042 | H_lesional_day15 | 794.06 | 76 |
GSM1296043 | L_lesional_day15 | 881.41 | 77 |
GSM1296037 | M_lesional_day15 | 454.04 | 66 |
GSM1296046 | P_lesional_day15 | 799.12 | 76 |
GSM1296044 | Q_lesional_day15 | 703.03 | 73 |
GSM1296045 | Y_lesional_day15 | 829.97 | 76 |
GSM1296025 | C_lesional_day15 | 283.8 | 59 |
GSM1296033 | D_lesional_day15 | 505.97 | 68 |
GSM1296027 | I_lesional_day15 | 332.22 | 62 |
GSM1296032 | J_lesional_day15 | 454.72 | 66 |
GSM1296024 | K_lesional_day15 | 207.34 | 54 |
GSM1296031 | W_lesional_day15 | 462.8 | 66 |
GSM1296028 | X_lesional_day15 | 332.25 | 61 |
GSM1296029 | Z_lesional_day15 | 348.75 | 61 |
GSM1296026 | F_lesional_day15 | 294.3 | 59 |
GSM1296030 | O_lesional_day15 | 329.29 | 61 |
GSM1296040 | S_lesional_day15 | 323.29 | 60 |
GSM1296036 | T_lesional_day15 | 310.02 | 59 |
GSM1296048 | V_lesional_day15 | 977.3 | 79 |
GSM1296059 | A_lesional_day43 | 480.64 | 67 |
GSM1296066 | G_lesional_day43 | 799.81 | 76 |
GSM1296060 | R_lesional_day43 | 715.36 | 73 |
GSM1296063 | U_lesional_day43 | 991.47 | 79 |
GSM1296064 | E_lesional_day43 | 1201 | 82 |
GSM1296067 | H_lesional_day43 | 594.17 | 70 |
GSM1296062 | M_lesional_day43 | 375.53 | 62 |
GSM1296068 | Q_lesional_day43 | 753.25 | 75 |
GSM1296050 | C_lesional_day43 | 466.06 | 67 |
GSM1296057 | D_lesional_day43 | 630.1 | 71 |
GSM1296052 | I_lesional_day43 | 344.08 | 62 |
GSM1296054 | J_lesional_day43 | 257.51 | 56 |
GSM1296049 | K_lesional_day43 | 275.54 | 58 |
GSM1296055 | W_lesional_day43 | 737.44 | 74 |
GSM1296053 | X_lesional_day43 | 213.72 | 53 |
GSM1296058 | Z_lesional_day43 | 466.87 | 66 |
GSM1296051 | F_lesional_day43 | 620.06 | 72 |
GSM1296056 | O_lesional_day43 | 863.34 | 77 |
GSM1296065 | S_lesional_day43 | 827.74 | 76 |
GSM1296061 | T_lesional_day43 | 320.31 | 60 |
GSM1296095 | A_non-lesional_pre-dose | 738.9 | 74 |
GSM1296120 | B_non-lesional_pre-dose | 836.34 | 76 |
GSM1296077 | C_non-lesional_pre-dose | 319.59 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 153.49 | 47 |
GSM1296104 | E_non-lesional_pre-dose | 817.89 | 76 |
GSM1296079 | F_non-lesional_pre-dose | 414.26 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 715.88 | 74 |
GSM1296110 | H_non-lesional_pre-dose | 571.06 | 69 |
GSM1296081 | I_non-lesional_pre-dose | 146.76 | 49 |
GSM1296091 | J_non-lesional_pre-dose | 599.54 | 71 |
GSM1296075 | K_non-lesional_pre-dose | 562.61 | 70 |
GSM1296112 | L_non-lesional_pre-dose | 806.63 | 76 |
GSM1296100 | M_non-lesional_pre-dose | 525.43 | 68 |
GSM1296087 | O_non-lesional_pre-dose | 277.17 | 59 |
GSM1296118 | P_non-lesional_pre-dose | 753.51 | 75 |
GSM1296114 | Q_non-lesional_pre-dose | 607.59 | 71 |
GSM1296097 | R_non-lesional_pre-dose | 721.8 | 74 |
GSM1296106 | S_non-lesional_pre-dose | 506.49 | 67 |
GSM1296102 | U_non-lesional_pre-dose | 332.87 | 60 |
GSM1296122 | V_non-lesional_pre-dose | 777.39 | 75 |
GSM1296089 | W_non-lesional_pre-dose | 400.93 | 63 |
GSM1296083 | X_non-lesional_pre-dose | 269.85 | 57 |
GSM1296116 | Y_non-lesional_pre-dose | 760.32 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 300.77 | 59 |